White cell toxicity: A predictive marker for survival after adjuvant and neoadjuvant chemotherapy for breast cancer?

被引：0
|
作者：
Pandha, HS [1 ]
Ashley, S [1 ]
Smith, IE [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Sutton SM2 5PT, Surrey, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26
引用
下载
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Predictive biomarkers of survival after neoadjuvant chemotherapy for breast cancer
    Galvez-Nino, Marco
    Roque, Katia
    Angel Bernabe, Luis
    Castillo, Miluska
    Sanchez, Joselyn
    Landa Baella, Maria
    Calderon, Gabriela
    De la Cruz, Miguel
    Dunstan, Jorge
    Abugatas, Julio
    Cotrina, Jose
    Castaneda, Carlos
    Gomez, Henry
    CANCER RESEARCH, 2020, 80 (04)
  • [2] Is sarcopenia associated with increased toxicity of neoadjuvant/adjuvant chemotherapy for breast cancer?
    Ueno, A.
    Yamaguchi, K.
    Sudo, M.
    Imai, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemoradiotherapy After Neoadjuvant Chemotherapy for Breast Cancer
    Marchand, Virginie
    Angelergues, Antoine
    Gobaux, Vanessa
    Hajage, David
    Kirova, Youlia M.
    Campana, Francois
    Dendale, Remi
    Reyal, Fabien
    Pierga, Jean-Yves
    Fourquet, Alain
    Bollet, Marc A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 425 - 429
  • [4] Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
    Skarping, Ida
    Fornvik, Daniel
    Sartor, Hanna
    Heide-Jorgensen, Uffe
    Zackrisson, Sophia
    Borgquist, Signe
    BMC CANCER, 2019, 19 (01)
  • [5] Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
    Ida Skarping
    Daniel Förnvik
    Hanna Sartor
    Uffe Heide-Jørgensen
    Sophia Zackrisson
    Signe Borgquist
    BMC Cancer, 19
  • [6] Adjuvant and neoadjuvant chemotherapy of breast cancer
    Untch, M.
    Thomssen, C.
    ONKOLOGE, 2015, 21 (03): : 231 - 238
  • [7] PREDICTIVE FACTORS OF SURVIVAL AFTER NEOADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST CANCER
    Matuschek, Christiane
    Budach, Wilfried
    Tamaskovics, Balint
    Fischer, Johannes
    Boelke, Edwin
    Corradini, Stefanie
    Kammers, Kai
    Kraemling, Carolin Nestle
    Fehm, Tanja
    Wollandt, Sylvia
    Speer, Vanessa
    Haussmann, Jan
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S38 - S39
  • [8] The Impact of Adjuvant Chemotherapy on Survival in Pancreatic Cancer after Neoadjuvant Treatment
    Gruhl, J. D.
    Francis, S.
    Christensen, M. C.
    Nevala-Plagemann, C.
    Lloyd, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E73 - E73
  • [9] HLA-J as a new predictive marker in breast cancer for neoadjuvant chemotherapy
    Wuerfel, F. M.
    Wirtz, R. M.
    Winterhalter, C.
    De Laco, P.
    Rosati, M.
    Veltrup, E.
    Martoni, A. A.
    Wuerfel, W.
    Zamagni, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E108 - E108
  • [10] Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer
    Iwamoto, Takayuki
    Kajiwara, Yukiko
    Zhu, Yidan
    Iha, Shigemichi
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 27
12345